Are you looking for the best treatment plan to lower your blood pressure? Join us for a Clinical Trial. You can make a difference. Blood pressure experts, supported by the Medical Research Council and the British Heart Foundation, are running a clinical trial that will help find the best treatment for each individual, because the response to treatment depends upon many factors such as age and ethnic background we hope that a broad range of people will participate. The treatment plan does not test any new drugs but uses the existing drugs which have been commonly used in trating hypertension for last 20 years. Contact us on email@example.com.
AIM HY (Ancestry and biological Informative Markers in the stratification of Hypertension) Inform, a programme funded by the Medical Research Council and the British Heart Foundation (BHF) is looking for participants. The objective of the AIM HY programme is to provide the best medicine for the individual suffering from hypertension. Since people of different ethnic group respond differently to high blood pressure medication, we are focusing on individuals of South East Asian and African/Caribbean ethnic cohorts as these are UK’s highest ethnic minority.
If you are of this ethnic background and would like to find the best medication for your high blood pressure, you can enquire about our Clinical Trial: Contact the Research Nurse closest to you. (Please see the Image) or write to us on firstname.lastname@example.org.
If you are aged 18 to 65 years you could take part in a project to find how treatment for high blood pressure should be “personalised”. Selection of medication from a wide choice of drugs is often by “trial and error”. Blood pressure experts, supported by the Medical Research Council and the British Heart Foundation, are running a clinical trial that will help find the best treatment for each individual, because the response to treatment depends upon many factors such as age and ethnic background we hope that a broad range of people will participate.
The trial will be suitable for people who have not yet started on treatment as well as those already on treatment.
The AIM HY Programme is funded by the Medical Research Council and the British Heart Foundation and the trial will be run at several centres in London and throughout the UK.
The ComparIsoN oF Optimal Hypertension RegiMens (INFORM) is a multi-site CTIMP trial recruiting 1320 multi-ethnic hypertensives in the UK examining whether more effective personalisation of antihypertensive treatment can be achieved based on ethnicity. INFORM is part of the Ancestry and biological Informative Markers for stratification of Hypertension (AIM HY) programme; which ultimately aims to deliver personalised treatment for high blood pressure, based on a single blood test to identify the best first line treatment. This should reduce the number of consultations; the time required to achieve optimal blood pressure control and contribute to better hypertension control in the UK.
A trial participant issued a statement: “Having entered the study after a short spell in hospital and asking the question of why I am medicated based on Caucasian research, I couldn’t have been happier to know that after the research program I would have finally be offered a medication that was most suited to me as an individual. All the staff on the study were so lovely and helpful and I always felt at ease, and most importantly knew that I was helping shape the future of people who suffer from hypertension. At the time I had a very busy job and although I could attend most of my pre-booked appointments, for the days that I had business clashes, Jane was very accommodating.
“I was enthralled to learn more about my health and actually having a monthly medical was very comforting. Previously having been prescribed 2 of the drugs I’d never really thought about the various side effects that I had suffered from. In my eyes, I was just told to take this particular medication by my GP. There was never any bedside manner with my GP and even with the difficulty in finding my veins to take blood, I was always made to feel comfortable on the study. If I can be of any help in the future, please do not hesitate to contact me and thank you for your time and giving me the comfort in finding the best suitable medication.”
This is an HRA Approved Study IRAS No 199550.